The short version
What teams need to understand
- Regulatory intelligence must be governed through structured processes and oversight.
- Regulatory changes must be communicated across all relevant functions.
- Regular governance meetings must review regulatory intelligence and actions.
- Decisions and actions must be documented and tracked.
- Continuous improvement must ensure the regulatory intelligence process remains effective.
- Inspection-ready evidence must demonstrate governance, communication, and ongoing enhancement of regulatory intelligence.
Regulatory expectation
What regulators expect
Each expectation should be supported by controlled documentation, traceable records, clear ownership, and evidence that the process works in practice.
- Regulatory intelligence must be governed and documented.
- Regulatory changes must be communicated across the organisation.
- Meetings must review and track regulatory changes and actions.
- Decisions must be documented and traceable.
- The regulatory intelligence process must be continuously improved.
Why it matters
What this means in practice
Inspectors assess whether regulatory intelligence is governed through structured meetings, communication processes, and continuous improvement. They review meeting records, communication of regulatory changes, and evidence that the regulatory intelligence system evolves over time.
Questions this page answers
Inspection evidence
Evidence teams should be able to show
Regulatory Intelligence Governance Meetings
- Monthly regulatory intelligence meetings
- Defined agenda covering new changes and actions
- Cross-functional participation (PV, RA, QA, Clinical)
- Documentation of discussions and decisions
Meeting Minutes and Action Records
- Recorded meeting minutes
- Documented decisions and approvals
- Action items with owners and deadlines
- Tracking of action completion
Communication of Regulatory Changes
- Internal communications to affected teams
- Distribution of regulatory updates
- Training or awareness sessions following changes
- Targeted notifications for urgent updates
Cross-Functional Coordination
- Collaboration between PV, RA, QA, Clinical, and affiliates
- Defined communication pathways
- Alignment of regulatory changes across functions
- Evidence of coordinated implementation
Continuous Improvement Records
- Periodic review of regulatory intelligence process
- Analysis of missed or delayed regulatory updates
- Updates to monitoring sources or processes
- Improvements based on audit findings or KPIs
Regulatory Basis (Primary Sources)
- GVP Module I - requirement for PV system governance and quality oversight
- GVP Module VI - requirement to ensure processes remain aligned with regulatory requirements
- ICH E2E - requirement for proactive and adaptive PV systems
- MHRA GPvP guidance - expectations for governance and communication of regulatory changes
- FDA pharmacovigilance guidance - requirement for maintaining compliant systems through oversight
Typical Inspection Questions (What Inspectors Ask)
- How do you govern regulatory intelligence?
- Show me minutes of your regulatory intelligence meetings.
- How are regulatory changes communicated to staff?
- How do you ensure actions are followed up?
- How do you improve your regulatory intelligence process over time?
Common failure patterns
What good looks like
- Regular governance meetings reviewing regulatory intelligence.
- Documented minutes, decisions, and action tracking.
- Effective communication of regulatory changes across teams.
- Strong cross-functional coordination.
- Continuous improvement based on feedback, audits, and metrics.
How teams operationalise it
- Schedule regular regulatory intelligence meetings.
- Use structured agendas and record meeting minutes.
- Communicate regulatory changes to all affected stakeholders.
- Track actions and follow up on completion.
- Review the effectiveness of the process periodically.
- Implement improvements based on findings and feedback.
From expectation to working control
Find the documentation that supports this work
Review the related toolkit to understand its purpose, included files, and how it supports this regulatory expectation.
Frequently asked questions
How is regulatory intelligence governed in pharmacovigilance?
Regulatory intelligence is governed through structured meetings, defined processes, and oversight by PV and regulatory leadership.
How are regulatory changes communicated within an organisation?
Regulatory changes are communicated through meetings, internal communications, training sessions, and targeted updates to affected teams.
Do inspectors review regulatory intelligence governance?
Yes. Inspectors review governance processes, meeting records, and communication of regulatory changes.
What is continuous improvement in regulatory intelligence?
Continuous improvement involves reviewing and enhancing the regulatory intelligence process based on performance, audits, and feedback.
Why are regulatory intelligence meetings important?
Meetings ensure regulatory updates are reviewed, decisions are made, and actions are tracked across the organisation.
How do you ensure regulatory intelligence actions are completed?
By tracking actions, assigning ownership, reviewing progress in meetings, and escalating delays where necessary.
Source boundary
Regulatory sources
These primary sources inform this structured interpretation. Always confirm current requirements against the original source and the requirements applicable to your organisation, product, and jurisdiction.
European Medicines Agency (EMA)
Guideline on good pharmacovigilance practices (GVP) - Module I
View sourceGuideline on good pharmacovigilance practices (GVP) - Module VI
View source
FDA
FDA Postmarketing Safety Reporting
View source
ICH
ICH E2E Pharmacovigilance Planning
View source
MHRA
Good Pharmacovigilance Practice (GPvP)
View source